Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease
Abroad (travel likely)RecruitingPHASE4
Conditions
Heart Failure with Reduced Ejection Fraction · End Stage Renal Disease on Dialysis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Taiwan University Hospital Hsinchu Branch, Hsinchu, Taiwan, Taiwan
Contact: Study coordinator (Chih-Cheng Wu, PhD)Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan, Taiwan
Contact: Study coordinator (Donna SH Lin, MD)
Study leads
Donna Shu-Han Lin, MD
Principal Investigator
Shin Kong Wu Ho-Su Memorial Hospital
Chih-Cheng Wu, MD. PhD
Principal Investigator
National Taiwan University Hsin-Chu Hospital